0
|
Notes
|
Mar. 31, 2025
|
|
Dec. 31, 2024
|
|
|
|
|
|
Assets
|
|
|
|
|
Cash and balances at the central bank
|
9
|
67,709,656
|
|
136,165,920
|
Due from banks
|
10
|
314,144,761
|
|
270,089,441
|
Loans and advances to banks, net
|
12
|
16,109,873
|
|
9,555,410
|
Loans and advances to customers, net
|
13
|
361,830,507
|
|
340,955,698
|
Derivative financial instruments
|
|
930,893
|
|
819,711
|
Financial investments
|
|
|
|
|
- Financial Assets at Fair Value through OCI
|
14
|
259,396,282
|
|
233,029,903
|
- Financial Assets at Amortized cost
|
14
|
188,018,472
|
|
167,276,956
|
Investments in subsidiaries and associates
|
15
|
853,165
|
|
871,525
|
Non-current assets held for sale
|
28
|
159,828
|
|
159,828
|
Other assets
|
16
|
40,366,933
|
|
44,175,232
|
Deferred tax assets
|
|
2,536,325
|
|
2,337,304
|
Property and equipment
|
17
|
4,597,989
|
|
3,881,620
|
Total assets
|
|
1,256,654,684
|
|
1,209,318,548
|
Liabilities and equity
|
|
|
|
|
Liabilities
|
|
|
|
|
Due to banks
|
18
|
4,051,736
|
|
2,317,715
|
Due to customers
|
19
|
996,119,565
|
|
967,895,387
|
Derivative financial instruments
|
|
78,314
|
|
100,571
|
Current income tax liabilities
|
|
5,565,862
|
|
18,327,968
|
Other liabilities
|
20
|
45,946,585
|
|
21,347,499
|
Issued debt instruments
|
21
|
5,044,951
|
|
5,067,781
|
Other loans
|
|
23,948,624
|
|
23,962,389
|
Other provisions
|
22
|
19,032,774
|
|
18,613,060
|
Total liabilities
|
|
1,099,788,411
|
|
1,057,632,370
|
Equity
|
|
|
|
|
Issued and paid capital
|
|
30,431,580
|
|
30,431,580
|
Reserves
|
|
87,850,844
|
|
63,125,912
|
Reserve for employee stock ownership plan (ESOP)
|
|
2,184,420
|
|
1,868,235
|
Retained earnings*
|
|
36,399,429
|
|
56,260,451
|
Total equity and net profit for the period / year
|
|
156,866,273
|
|
151,686,178
|
Total liabilities and equity
|
|
1,256,654,684
|
|
1,209,318,548
|
|
|
|
##
|
|
|
|
|
|
|
The accompanying notes are an integral part of these financial statements.
|
|
|
|
|
(Review report attached)
|
|
|
|
|
*Including net profit for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Islam Zekry
|
Hisham Ezz Al-Arab
|
Group CFO & Executive Board Member
|
CEO & Executive Board Member
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Separate Interim Income Statement for the period ended March 31, 2025
|
|
|
Last 9 Months
|
|
|
Last 9 Months
|
|
Notes
|
Mar. 31, 2025
|
|
|
Mar. 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and similar income
|
|
52,299,641
|
|
|
36,544,341
|
Interest and similar expense
|
|
(27,003,143)
|
|
|
(17,784,185)
|
Net interest income
|
|
25,296,498
|
|
|
18,760,156
|
|
|
|
|
|
|
Fee and commission income
|
|
3,510,324
|
|
|
2,684,283
|
Fee and commission expense
|
|
(1,586,144)
|
|
|
(1,118,950)
|
Net fee and commission income
|
|
1,924,180
|
|
|
1,565,333
|
|
|
|
|
|
|
Dividend income
|
|
12,751
|
|
|
610
|
Net trading income
|
6
|
641,395
|
|
|
16,202,679
|
Profits (Losses) on financial investments
|
14.1
|
376,684
|
|
|
224,271
|
Administrative expenses
|
|
(3,748,977)
|
|
|
(2,840,462)
|
Other operating income (expenses)
|
7
|
(1,735,421)
|
|
|
(14,923,188)
|
Impairment release (charges) for credit losses
|
|
(68,528)
|
|
|
(1,482,187)
|
Profit before income tax
|
|
22,698,582
|
|
|
17,507,212
|
|
|
|
|
|
|
Income tax expense
|
26
|
(6,514,216)
|
|
|
(5,722,492)
|
Deferred tax assets (Liabilities)
|
26
|
411,246
|
|
|
161,877
|
Net profit for the period
|
|
16,595,612
|
|
|
11,946,597
|
|
|
|
|
|
|
Earnings per share
|
8
|
|
|
|
|
Basic
|
|
4.83
|
|
|
3.47
|
Diluted
|
|
4.79
|
|
|
3.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Islam Zekry
|
Hisham Ezz Al-Arab
|
Group CFO & Executive Board Member
|
CEO & Executive Board Member
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Separate Interim Statement of Comprehensive Income for the period ended March 31, 2025
|
Last 9 Months
|
Last 9 Months
|
|
Mar. 31, 2025
|
|
Mar. 31, 2024
|
|
|
|
|
|
|
Net profit for the period
|
16,595,612
|
|
11,946,597
|
|
|
|
|
|
|
Net change on financial assets at fair value through comprehensive income after tax
|
2,141,325
|
|
1,977,715
|
|
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income
|
841,407
|
|
745,406
|
|
Total comprehensive income for the period
|
19,578,344
|
|
14,669,718
|
|
|
|
|
|
|
|
|
|
Condensed Separate Interim Cash Flows for the period ended March 31, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes
|
Mar. 31, 2025
|
Mar. 31, 2024
|
|
|
|
|
Cash flow from operating activities
|
|
|
|
Profit before income tax
|
|
22,698,582
|
17,507,212
|
Adjustments to reconcile profits to net cash provided by operating activities
|
|
|
|
Fixed assets depreciation
|
17
|
353,476
|
261,427
|
Impairment release/charge for credit losses (Loans and advances to customers and banks)
|
|
(1,099,420)
|
1,772,387
|
Other provisions release/charge
|
22
|
317,074
|
40,759
|
Impairment release/charge for credit losses (due from banks)
|
|
144,661
|
(53)
|
Impairment release/charge for credit losses (financial investments)
|
|
1,023,287
|
(290,147)
|
Impairment release/charge for other assets
|
|
-
|
(4,782)
|
Exchange revaluation differences for financial assets at fair value through OCI and AC
|
|
212,785
|
(17,328,576)
|
Revaluation differences impairment charge for Financial Assets at Fair value through OCI
|
|
(13,337)
|
1,130,412
|
Revaluation differences impairment charge for Financial Assets at Amortized cost
|
|
1,240
|
95,225
|
Revaluation differences impairment charge for due from banks
|
|
-
|
101
|
Net utilized / recovered of other provisions
|
22
|
(520)
|
(4,517)
|
Exchange revaluation differences of other provisions
|
22
|
103,160
|
3,574,794
|
Profits/losses from selling property and equipment
|
|
(6,006)
|
-
|
Profits/losses from selling financial investments at fair value through OCI
|
14.1
|
(195,124)
|
(224,271)
|
Profits/losses from selling investments in associates
|
14.1
|
(181,560)
|
-
|
Share based payments
|
|
316,185
|
300,000
|
Operating profits before changes in operating assets and liabilities
|
|
23,674,483
|
6,829,971
|
|
|
|
|
Net decrease / increase in assets and liabilities
|
|
|
|
Due from banks
|
|
121,695,741
|
42,289,034
|
Financial assets at fair value through P&L
|
|
-
|
(974,297)
|
Derivative financial instruments
|
|
(142,036)
|
154,638
|
Loans and advances to banks and customers
|
|
(26,329,852)
|
(36,747,889)
|
Other assets
|
|
6,045,337
|
(5,850,432)
|
Due to banks
|
18
|
1,734,021
|
(6,855,319)
|
Due to customers
|
19
|
28,224,178
|
117,099,122
|
Current income tax obligations paid
|
|
(948,354)
|
(276,723)
|
Other liabilities
|
|
5,716,835
|
1,851,912
|
Net cash generated from (used in) operating activities
|
|
159,670,353
|
117,520,017
|
|
|
|
|
Cash flow from investing activities
|
|
|
|
Proceeds from sale of investments in associates
|
|
226,698
|
4,782
|
Payments for investment in subsidiaries
|
|
(140,000)
|
-
|
Payments for purchases of property, equipment and branches construction
|
|
(3,193,660)
|
(366,618)
|
Proceeds from selling property and equipment
|
|
6,006
|
-
|
Proceeds from redemption of financial assets at amortized cost
|
|
2,537,401
|
285,507
|
Payments for purchases of financial assets at amortized cost
|
|
(23,457,385)
|
(53,240,480)
|
Payments for purchases of financial assets at fair value through OCI
|
|
(29,004,342)
|
(26,284,875)
|
Proceeds from selling financial assets at fair value through OCI
|
|
6,057,967
|
26,380,625
|
Net cash generated from (used in) investing activities
|
|
(46,967,315)
|
(53,221,059)
|
|
|
|
|
|
|
Mar. 31, 2025
|
Mar. 31, 2024
|
|
|
|
|
Cash flow from financing activities
|
|
|
|
Other loans
|
|
(13,765)
|
6,700,881
|
Dividends paid
|
|
(14,160,152)
|
(5,078,792)
|
Issued debt instruments
|
|
(22,830)
|
1,626,167
|
Net cash generated from (used in) financing activities
|
|
(14,196,747)
|
3,248,256
|
|
|
|
|
Net (decrease) increase in cash and cash equivalent during the period
|
|
98,506,291
|
67,547,214
|
Beginning balance of cash and cash equivalent
|
|
227,028,744
|
233,912,193
|
Cash and cash equivalent at the end of the period
|
|
325,535,035
|
301,459,407
|
|
|
|
|
Cash and cash equivalent comprise:
|
|
|
|
Cash and balances at the central bank
|
9
|
67,709,656
|
36,542,863
|
Due from banks
|
|
314,289,639
|
291,980,200
|
Treasury bills and other governmental notes
|
11
|
115,964,828
|
119,754,167
|
Obligatory reserve balance with CBE
|
|
(43,718,398)
|
(19,383,018)
|
Due from banks with maturity more than three months
|
|
(14,867,792)
|
(7,554,480)
|
Treasury bills and other governmental notes with maturity more than three months
|
|
(113,842,898)
|
(119,880,325)
|
Total cash and cash equivalent
|
|
325,535,035
|
301,459,407
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Separate Interim statement of changes in shareholders' equity
|
|
Issued and paid capital
|
Legal reserve
|
General reserve
|
General risk reserve
|
Capital reserve
|
Reserve for financial assets at fair value through OCI
|
Banking risks reserve
|
Retained earnings
|
Reserve for employee stock ownership plan
|
Total
|
Mar. 31, 2024
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at 1 January 2024
|
30,195,010
|
4,770,354
|
39,840,707
|
1,549,445
|
21,155
|
(16,808,265)
|
15,230
|
29,230,360
|
1,486,010
|
90,300,006
|
Transferred to reserves
|
-
|
1,438,320
|
21,958,960
|
-
|
1,663
|
-
|
-
|
(23,398,943)
|
-
|
-
|
Dividend paid
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(5,366,429)
|
-
|
(5,366,429)
|
Net profit for the period
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
11,946,597
|
-
|
11,946,597
|
Net change on financial assets at fair value through OCI after tax
|
-
|
-
|
-
|
-
|
-
|
1,977,715
|
-
|
-
|
-
|
1,977,715
|
Transferred (from) to banking risk reserve
|
-
|
-
|
-
|
-
|
-
|
-
|
2,694
|
(2,694)
|
-
|
-
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI
|
-
|
-
|
-
|
-
|
-
|
745,406
|
-
|
-
|
-
|
745,406
|
Cost of employees stock ownership plan (ESOP)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
300,000
|
300,000
|
Balance at 31 March 2024
|
30,195,010
|
6,208,674
|
61,799,667
|
1,549,445
|
22,818
|
(14,085,144)
|
17,924
|
12,408,891
|
1,786,010
|
99,903,295
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued and paid capital
|
Legal reserve
|
General reserve
|
General risk reserve
|
Capital reserve
|
Reserve for financial assets at fair value through OCI
|
Banking risks reserve
|
Retained earnings
|
Reserve for employee stock ownership plan
|
Total
|
Mar. 31, 2025
|
|
|
|
|
|
|
|
|
|
|
Beginning Balance at 1 January 2025
|
30,431,580
|
6,208,674
|
62,422,792
|
1,549,445
|
22,818
|
(7,095,741)
|
17,924
|
56,260,451
|
1,868,235
|
151,686,178
|
Transferred to reserves
|
-
|
2,771,284
|
18,971,298
|
-
|
2,246
|
-
|
-
|
(21,744,828)
|
-
|
-
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(14,714,434)
|
-
|
(14,714,434)
|
Net profit for the period
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
16,595,612
|
-
|
16,595,612
|
Net change on financial assets at fair value through OCI after tax
|
-
|
-
|
-
|
-
|
-
|
2,141,325
|
-
|
-
|
-
|
2,141,325
|
Transferred (from) to banking risk reserve
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,628)
|
2,628
|
-
|
-
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI
|
-
|
-
|
-
|
-
|
-
|
841,407
|
-
|
-
|
-
|
841,407
|
Cost of employees stock ownership plan (ESOP)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
316,185
|
316,185
|
Balance at 31 March 2025
|
30,431,580
|
8,979,958
|
81,394,090
|
1,549,445
|
25,064
|
(4,113,009)
|
15,296
|
36,399,429
|
2,184,420
|
156,866,273
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|